ACRS: Aclaris Therapeutics Inc

1.55 USD 0.06 (3.73%)

Setor: Cuidados de saúde Base: US Dollar Moeda de lucro: US Dollar

A taxa do ACRS para hoje mudou para -3.73%. Paralelamente, o preço mais baixo no mercado atingiu 1.50 e o mais alto foi 1.86.

Veja a dinâmica do par de moedas Aclaris Therapeutics Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.

Tela cheia

ACRS Notícias

Zacks 14:00 Aclaris Therapeutics (ACRS) Expected to Beat Earnings Estimates: Should You Buy?
Investing 21:28 Aclaris Therapeutics stock soars after positive Phase 2a trial results
Investing 20:09 Aclaris reports positive results from ATI-2138 atopic dermatitis trial
Investing 17:01 Aclaris Therapeutics at HCW Conference: Strategic Moves and Future Plans
Investing 13:37 Aclaris Therapeutics joins Russell 3000 and Russell 2000 indexes
Investing 20:48 Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference
Investing 11:29 Aclaris Therapeutics initiates Phase 1 trial for ATI-052 antibody
Investing 11:20 Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052
Investing 11:04 InvestingPro’s Fair Value model captures 67% upside in Aclaris Therapeutics
Investing 11:32 H.C. Wainwright maintains Buy on Aclaris stock, $16 target
Investing 18:02 Aclaris Therapeutics at Jefferies Conference: Strategic Pipeline Advances
Investing 11:05 Aclaris begins phase 2 trial for atopic dermatitis drug
Investing 13:32 Aclaris Therapeutics to Participate in Two June Healthcare Conferences
Investing 12:22 Wedbush sets Aclaris stock Outperform with $8 target
Benzinga 11:43 This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Aclaris Therapeutics (NASDAQ:ACRS), Alkermes (NASDAQ:ALKS)
Investing 19:09 Insurance broker Acrisure valued at $32 billion in funding round led by Bain Capital
Investing 12:44 H.C. Wainwright cuts Aclaris stock price target to $16
Seeking Alpha 12:09 Aclaris: History Of Failures, And Recent Acquisition Of A 'Blockbuster Potential' Molecule

Faixa diária

1.50 1.86

Faixa anual

1.05 5.17

Fechamento anterior: 1.55
Open: 1.61

Bid: 1.55
Ask: 1.85

Low: 1.50
High: 1.86

Volume: 4.911 K

Mudança diária: -3.73%
Mudança mensal: 7.64%

Mudança de 6 meses: -35.95%
Mudança anual: 12.32%

30 julho, quarta-feira